Early recurrence of retinopathy of prematurity after initial intravitreal ranibizumab monotherapy —experience from a tertiary referral center in Abu Dhabi, UAE

To evaluate recurrence rate of retinopathy of prematurity (ROP) after initial intravitreal ranibizumab injection (IVR) monotherapy for infants with type 1 retinopathy of prematurity (zone I and posterior zone II) and threshold disease

Source: Journal of AAPOS - July 31, 2019 Category: Opthalmology Authors: Tin T. Chan, Abeer A. Al Ali, Ahmed A. ElBarky, Fiona F. Dean, Fatima F. Habroosh, Manal M. Alzaabi, Rawdha R. Al Nuaimi Source Type: research